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γ-Secretase and signal peptide peptidase (SPP) are unusual aspartyl proteases of the GxGD 
type, which mediate intramembrane proteolysis. Besides SPP, a family of SPP-like proteins 
(SPPLs) of unknown function was identified. We demonstrate that SPPL2b utilizes multiple 
intramembrane cleavages to liberate the TNFα intracellular domain into the cytosol and to 
release the C-terminal counterpart into the lumen. These findings suggest common 
principles of regulated intramembrane proteolysis by GxGD type aspartyl proteases. 
 
Extensive work on sterol-regulated proteolysis, rhomboids, γ-secretase, and signal peptide 
peptidase (SPP) 1 led to the novel concept of regulated intramembrane proteolysis.  Beside SPP, 
several SPP homologues (SPP-like proteases; SPPL) of unknown function were identified by 
database searches 2,3.  We recently mutagenized the aspartate residue within the GxGD motif of 
SPPL2 and SPPL3 in zebrafish and found that over-expression of such dominant negative 
constructs phenocopies a loss of function 4.  This strongly indicates that all SPPLs are proteases 
of the GxGD family. Whereas SPP is known to be involved in clearance of signal peptides as 
well as in the processing of hepatitis C viral core protein 3, substrates for SPPLs have not been 
found.  In order to identify putative substrates for SPPLs, we focused on SPPL2a/b, since these 
members of the SPPL family are of specific interest due to their unexpected localization in late 
endosomes and at the plasma membrane 4 (and accompanying manuscript by Friedmann et al.), 
which suggests a function independent of signal peptide cleavage. Using our knowledge on the 
subcellular localization 4 as well as previous work on the substrate requirements for SPP 5 we 
identified tumor necrosis factor-α (TNFα) as a candidate substrate (see also accompanying 
manuscript by Friedmann et al.). To verify selective TNFα processing by SPPL2a/b cell lysates 
from human embryonic kidney 293 cells co-expressing TNFα and SPP or the members of the 
SPPL family were investigated for the presence of the TNFα intracellular domain (ICD) (for a 
schematic model of TNFα processing and terminology see Fig. 1F). Indeed, TNFα ICD 
generation is only observed upon co-expression of SPPL2a or SPPL2b, whereas SPP and SPPL3 
did not support TNFα proteolysis (Fig. 1A). Since SPPL2a and b appear to act redundantly (Fig. 
1A) and the zebrafish genome encodes only one SPPL2 gene 4, we focused in the following 
exclusively on SPPL2b. Liberation of the TNFα ICD (sometimes occurring as a closely spaced 
doublet; Fig. 1B) is dependent on the aspartate residue within the C-terminal active site of 
SPPL2b, since the TNFα N-terminal fragment (NTF) accumulates upon inactivation of SPPL2b 
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(Fig. 1B). Moreover, as it is the case for γ-secretase substrates, the TNFα NTF co-
immunoprecipitates with SPPL2b upon its inactivation, either by mutagenesis (Fig. 1C lower 
panel) of the critical aspartate within the GxGD motif or by use of selective inhibitors (Fig. 1C 
lower panel).  Surprisingly, and in contrast to γ-secretase 6, significant amounts of full-length 
TNFα were also found to specifically co-purify with SPPL2b (Fig. 1C upper panel).  Since TNFα 
FL also co-purifies with SPPL2b it may be cleaved to some extend directly by SPPL2b.  This is 
consistent with the fact that SPPL2b acts independent of a docking protein, such as Nicastrin, 
which is responsible for the size selection of γ-secretase substrates 7.   
TNFα ICD generation predicts that its C-terminal counterpart (TNFα C-domain) is secreted into 
the media in analogy to processing of γ-secretase substrates 1.  To facilitate isolation of TNFα C-
domain, we generated TNFα ∆E, where the ectodomain is deleted.  Similar constructs greatly 
facilitated the investigation of Notch, APP, and CD44 endoproteolysis by γ-secretase 1. As shown 
in Fig. 1D (lower panel) cells expressing proteolytically active SPPL2b secreted the TNFα C-
domain, whereas no such peptides but large amounts of uncleaved TNFα∆E were observed upon 
expression of SPPL2b D/A (Fig. 1D upper and lower panel).   
After demonstrating selective TNFα ICD and TNFα C-domain generation, we investigated 
whether these TNFα ICDs can be generated endogenously.  Since the TNFα ICD is very unstable 
(data not shown), which makes the in vivo detection difficult, we turned to in vitro assays similar 
to those we introduced to isolate the highly unstable APP ICD (AICD) 8. After demonstrating 
specific in vitro generation of TNFα ICD upon overepression of SPPL2b (Fig. 1E, left panel), we 
repeated the same type of experiments with membrane extracts obtained from cells not 
transfected with SPPL2b.  This revealed that under endogenous conditions, TNFα ICD is 
generated and its production is inhibited by the SPP/SPPL specific inhibitor (Z-LL)2-ketone (this 
inhibitor does not block γ-secretase) 9 (Fig. 1E, right panel). Together with the data in Fig. 1A, 
which demonstrate selective TNFα ICD generation by SPPL2a/b, this strongly suggests that 
endogenous SPPL2a/b generate TNFα ICD.   
Next, the cleavage sites of the ICD and the TNFα C-domain were determined by mass 
spectrometry and radiosequencing.  Mass spectrometry of purified ICDs revealed major 
intramembrane cleavage sites after amino acid 34 and 39 (Fig. 2A,C).  Additional peptides 
ranging from 25 to 29 amino acids (Fig. 2A,C) suggest degradation by a cytoplasmic 
carboxypeptidase (blue arrows in Fig. 2C).  This is supported by the observation that TNFα ICD 
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can be detected as a doublet in some cases (Fig. 1B). Furthermore, over time the higher molecular 
weight peptide is trimmed to the smaller peptide (data not shown).  Radiosequencing of the 
TNFα C-domain demonstrates a major cleavage after Cys 49 (evident from large peaks of 3H-Phe 
at cycle 4, 3H-Val at cycle 6, 3H-Leu at cycle 1 and 2 and 3H-Ile at cycle 7) as well as a lesser 
abundant cleavage after Leu 51 (evident from 3H-Phe peak at cycle 2, 3H-Val peak at cycle 4 and 
3H-Ile at cycle 5) (Fig. 2B,C). Both cleavage sites were also confirmed by mass spectrometry 
(data not shown).  Similar data were obtained upon sequencing of 3H-Phe-labeled TNFα C-
domain generated by cells expressing endogenous SPPL2 (Suppl. Fig. S2 B).  ICDs with C-
termini around amino acids 49 or 51 were not obtained.  Likewise, we obtained no evidence for 
longer TNFα C-domains.   
Our data thus demonstrate a surprising similarity in the cleavage pattern of γ-secretase 
and SPPL2b, although both proteases show fundamental differences with respect to complex 
formation (γ-secretase requires PS, Aph-1, Nct, and Pen-2 10, while SPPL2 activity is massively 
increased upon overexpression of a single cDNA), substrate orientation and limited sequence 
homology. SPPL2b, like γ-secretase, performs multiple intramembrane cleavages separated by a 
number of amino acids (Fig. 2C).  It is even tempting to speculate that this may include an ε- 
(after amino acid 34) 11 and ζ-like 12 cut (after amino acid 39) as well as a γ-like cleavage (after 
amino acids 49 and 51) at the luminal side of the membrane.  Interestingly, the latter occurs as 
two cuts very similar to the γ-secretase cleavage, which liberates the 40 and 42 amino acid 
amyloid β-peptide.  Moreover, similar to γ-secretase, RIP of TNFα by SPPL2 generates a 
cytoplasmic cleavage product, which is required for cellular signaling (see accompanying 
manuscript by Friedmann et al.).  Strikingly, for SPPL2b, the active sites are reversed within the 
membrane to accommodate type-2-oriented substrates.  As for γ-secretase, the question arises of 
how one protease activity can cut its substrate at several sites.  Like presenilin 13, the 
catalytically active component of the γ-secretase complex 1, SPP and all SPPLs appear to occur 
as homodimers 4,14.  Moreover, at least for SPP, it has been shown that dimerization facilitates 
the binding of an active-site directed photoaffinity labeled γ-secretase inhibitor, suggesting that 
dimerization is required to form the fully active catalytic site of SPP 14. Our findings thus 
demonstrate a common multiple intramembrane cleavage by GxGD-type aspartic proteases, 
which is required for the liberation of a signaling factor into the cytoplasm and the secretion of 
Aß-like domains in the extracellular space. 
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Figure 1: Endoproteolytic processing of TNFα  
(A) The TNFα ICD is selectively generated by SPPL2a/b. (B) TNFα ICD production is abolished 
upon co-expression of an inactive SPPL2b mutant. (C) TNFα NTF (lower panel) and TNFαFL 
(upper panel) co-isolate with inactivated SPPL2b. Asterisk: IgG light chain. Full length blot 
including input control is presented as Suppl. Fig. S1. (D) Generation of the TNFα C-domain by 
cells expressing wt SPPL2b but not by cells expressing SPPL2b D421A. (E) In vitro generation 
of TNFα ICD.  Note endogenous TNFα ICD generation (longer exposure in the right bottom 
panel). (F) Model illustrating the processing of TNFα. 
 
Figure 2: Intramembrane cleavage of TNFα 
(A) MALDI-TOF-MS analysis of TNFα ICDs. For calculation of the respective masses see 
Suppl. Fig. S2 A. (B) Cells cotransfected with TNFα and SPPL2b wt were labelled with either 
3H-Phenylalanine ( ), 3H-Valine ( ),3H-Leucine ( ) or 3H-Isoleucine ( ).    Radiosequencing 
of the isolated TNFα C-domain reveals a major cleavage after Cys 49 and a lesser cleavage after 
Leu 51.  (C) Model showing the multiple cleavages of TNFα by SPPL2b. 
   
 
MATERIALS AND METHODS 
 
Cell culture, cDNAs and transfection 
HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium with Glutamax (DMEM; 
Gibco Life Sciences) supplemented with 10% fetal calf serum (Gibco Life Sciences). The cell 
lines stably overexpressing SPP, SPPL2b and SPPL3 have been described previously 4. The 
inactive SPPL2b D421A mutant was generated by polymerase chain reaction mutagenesis and 
subcloned into the EcoRI/XhoI sites of pcDNA4/ myc-His (Invitrogen Life Sciences).  
The TNFα cDNA was purchased from ATCC (clone AAA61198) and after addition of a N-
terminal Flag tag (DYKDDDDK) after the starting methionine and a C-terminal HA tag 
(YPYDVPDYA) subcloned into the Hind III/ Not I sites of Peak 12. The C-terminally truncated 
TNFα ∆E construct was generated by inserting a stop codon after amino acid 80.  This construct 
also contains a N-terminal Flag tag and a C-terminal HA tag. TNFα ∆E was subcloned into the 
Hind III/ Xho I sites of pcDNA 3.1. Hygro + (Invitrogen Life Sciences). TNFα cDNA was 
cotransfected with the respective SPP/ SPPLs using Lipofectamine 2000 (Invitrogen Life 
Sciences) according to the supplier’s instructions.  All cDNA constructs were sequenced for 
verification. 
 
Antibodies, immunoprecipitation and immunoblotting 
The monoclonal anti-myc antibody 9E10 was obtained from the hybridoma bank and the anti-
HA-peroxidase coupled 3F10 antibody from Roche. The monoclonal anti-Flag M2 and the 
polyclonal HA 6908 antibody were obtained from Sigma (St. Louis, MO).  For co-
immunoprecipitation cells were lysed in assay buffer (25 mM HEPES-KOH, pH 7,6, 100 mM 
KOAc, 2 mM Mg(OAc)2, 1 mM DTT) containing 1% CHAPSO on ice for 30 min. Lysates were 
clarified by centrifugation for 20 min at 16000 x g and immunoprecipitated for 4 hrs at 4 °C.  
 
TNFα in vitro assay 
Membranes of HEK 293 cells stably expressing the indicated SPPL2b derivative and transiently 
expressing TNFα were prepared as described before 10.  Membranes were subsequently re-
suspended in assay buffer (see above) and incubated for the respective time points at 37 oC. After 
incubation lipids were extracted using Chloroform/ Methanol (1:2) and proteins were subjected to 
SDS-polyacrylamid electrophoresis and immunoblotting. Were indicated (Z-LL)2-Ketone 




TNFα in vitro assays were performed as described above.  After incubation at 37 oC membranes 
were solubilized in STEN-Lysis buffer (50 mM Tris, pH 7,6, 150 mM NaCl, 2 mM EDTA, 1% 
Nonidet P-40 (NP-40), 1% Triton X-100) and TNFα ICD peptides were immunoprecipitated 
using anti-Flag M2 agarose, affinity gel (Sigma). Immunoprecipitations were carefully washed 6 
times with 1x PBS and 2 times with dH2O. Protein was subsequently eluted by using formic acid. 
Samples were subjected to analysis by mass spectrometry using as matrix α-cyano-4-
hydroxycinnamic acid (Sigma) as described 10. Mass spectra were recorded on a Voyager-DE 
STR mass spectrometer (Applied Biosystems) in the linear mode with external calibration.  
 
Radiosequencing 
HEK 293 cells stably expressing SPPL2b wt and transiently expressing TNFα∆E were 
metabolically labeled with [3H]valine, [3H]phenylalanine, [3H]leucine or [3H]isoleucine 
(Hartmann Analytic, Germany) for 16 hours, supernatants were collected and TNFα C-domain 
peptides were isolated by immunoprecipitation with antibody HA6908 (Sigma) separated by 
SDS-PAGE and transferred to PVDF membrane.  Radiolabeled proteins were detected by 
autoradiography, excised, and subjected to automated Edman chemistry in an Applied 
Biosystems Model 475A sequenator. Amino-acid anilinothiazolinones were extracted with n-
butyl chloride, transferred into 7 ml scintillation vials, and assayed for radioactivity after addition 
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Supplementary Information Figure S1: TNFα NTF co-isolates with inactivated SPPL2b
Co-immunoprecipitations of TNFα with SPPL2b (left side) reveal significant amounts of  TNFa NTF co-
isolating with inactivated SPPL2b. TNFαFL also co-immunoprecipitates with SPPL2b wt as well as with 
inactivated SPPL2b. Parallel samples were immoprecipitated with anti flag M2 agarose (Sigma) and bloted
with the monoclonal M2 antibody against the N-terminal flag Tag of TNFa, to show the respective input 
(right side).Asterisk: IgG

























































































Flag M2 (TNFα) Flag M2 (TNFα)
Flag M2 (TNFα)
Supplementary Information Figure S2: 
A) MALDI-TOF-MS analysis of TNFα ICDs: Calculation of the peptide masses refers to the 
sequences of TNFα including a N-terminal Flag-tag (bold). The mass spectra show TNFα peptides, 
likely carrying an N-terminal acetyl group, which results in an increase in mass by 42 amu. The 
respective peptides were not detected upon expression of SPPL2b D421A. The smaller fragments (1-25 
to 1-29) are likely due to degradation by a carboxypeptidase activity. mass calc.: Calculated molecular 
mass. B) Radiosequencing of TNFα C-domain generated by endogenous SPPL2: Cells only 
transfected with TNFα were labelled with 3H-Phenylalanine ( ). Radiosequencing of the isolated TNFα
C-domain reveals identical cleavage sites as found for overexpressed SPPL2b. 
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1-39 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFL 5340 5382 
1-34 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQGSRRCLFLS 4732 4774 
1-29 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQGSRR 4169 4211 
1-28 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQGSR 4013 4055 
1-27 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQGS 3857 3899 
1-26 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQG 3770 3812 
1-25 MDYKDDDDKSTESMIRDVELAEEALPKKTGGPQ 3713 3755 
 
